News

Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies

Featured Posts

The Vaccine Trenches

Key breakthroughs leading to the powerful mRNA vaccines against COVID-19 were forged at Penn. That triumph was almost 50 years in the making, longer on obstacles than celebration, and the COVID-19 vac

MedCity Spotlight Video: How PCI is combating Covid-19

As part of MedCity's 2021 INVEST conference, Cesar de la Fuente, presidential assistant professor at the University of Pennsylvania, explains the value of the rapid low-cost diagnostic test he has dev

Vivodyne pioneers bioengineering tools

A Penn-founded biotech company that helps scientists test drugs and therapeutics has raised $4 million in order to more widely adopt their platform that embraces “organs on chip” technology. Vivodyne'

Class of 2021 President’s Engagement and Innovation Prize winners announced

The Prizes enable students to take on post-graduation projects that make a positive, lasting difference in the world. Three students were named 2021 President’s Innovation Prize recipients: Aris Saxen

Philadelphia-area life sciences companies reeled in nearly $3B in the 1st quarter

Strong investor interest in local life sciences companies continued during the first quarter of 2021 with 16 Philadelphia-area businesses reeling in more than $2.9 billion.

Biosealant therapy might help stabilize injury caused by cartilage damage: Study

According to new Penn research, a new biosealant therapy and hyaluronic acid hydrogel system at least temporarily stops cartilage degeneration that commonly occurs after injury and causes pain in join

NextUp: The Philly startup using biosensors to combat food waste and improve supply chains

Strella Biotechnology monitors an increase in ethylene production in fruit, signaling when produce needs to get to consumers before spoiling.

Filter

Success Stories

Highlights of the PCI news focused on Penn commercialization accomplishments

All Success Stories